GHK-Cu is a copper-binding peptide compound widely referenced in preclinical and laboratory research for its interaction with cellular signalling and regenerative pathways
For instance, according to the India Brand Equity Foundation (IBEF), Indias domestic pharmaceutical market is expected to be valued at US$ 42,000 Million in 2021 and is expected to reach US$ 64,000 Million by 2024 and further estimated to reach US$ 120-130 billion by 2030
For severe deficiencies, it can take even longer, since your vitamin stores are extremely depleted
The GLOW blend combining GHK-Cu, TB-500, and BPC-157 has gained popularity in regenerative research circles, with typical ratios of 27 mg GHK-Cu, 10 mg TB-500, and 5 mg BPC-157
It also has a strong research base, with studies looking at how it interacts with cell signaling and the extracellular matrix (Pickart & Margolina, 2018)
For patients with widespread psoriasis affecting large body surface areas, topical application to every plaque becomes impractical